Form 4: OS Therapies Inc: Shalom Auerbach Sells 82,000 Shares of Common Stock

Shalom Auerbach, a director and 10% owner of OS Therapies Inc, sold 82,000 shares of common stock at an average price of $1.999 per share on May 7, 2025.

Summary

• On May 7, 2025, Shalom Auerbach, a director and 10% owner of OS Therapies Inc (OSTX), sold 82,000 shares of common stock.
• The shares were sold at a weighted average price of $1.999 per share, with individual transaction prices ranging from $1.69 to $2.22.
• Following the transaction, Auerbach directly owns 23,371 shares and indirectly owns 2,664,199 shares through Einodmil LLC.
• Auerbach is the Principal of Einodmil LLC and exercises voting and dispositive power over the shares held by Einodmil.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the sale of shares by a significant shareholder, which could indicate a lack of confidence or a need for liquidity. However, the filing is a routine regulatory disclosure.

Negatives

• A significant shareholder selling a large block of shares could be perceived negatively by the market.

Risks

• Further sales by Auerbach could put downward pressure on the stock price.
• The reason for the sale is not disclosed, which could lead to speculation and uncertainty.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the buying and selling activities of company insiders. This sale is specific to OS Therapies and its major shareholder.

Stakeholder Impact

• Shareholders may react to the news of the sale, potentially impacting the stock price.

Key Dates

Keywords

OS Therapies, OSTX, Shalom Auerbach, stock sale, Form 4, Einodmil LLC, beneficial ownership, director, 10% owner